The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Put an order in and only got 500 quids worth.. still NT to buy?
If the new CEO can create some value out of the IP they have then people buying at these prices could do very well. Tiny tiny Mcap of 250k. IPO was at around 20m a couple years ago
Hopefully this helps it rise
Go on lads 😂
Think I may have stumbled across an extremely interesting minnow here. Following the RNS put out this morning announcing the appointment of Anthony Tennyson as the new CEO there could be very exciting times ahead. His CV looks exceptional and has also a background in finance having worked at Merrill Lynch and Bank of Ireland both blue chip names. Besides that his career has been in Life Sciences and this is exactly what this company needs. With such a tiny market cap there is huge potential upside here.
Seems they will convert the £100k loan to shares....in conjunction with introducing stakeholder investment funding...Nick's a financial money PR man with stockbroker experience.....I think today is overdone by far and with market cap @ £200k etc.
There is easily enough assets to move than cover that......so I've taken a small stock holding position.....intend to increse when more capital raise information is disclosed!
GLA
Https://www.linkedin.com/in/nicholas-nelson-05a926118?originalSubdomain=uk
New director has a good record has also provided a 100k loan showing confidence of turning this around
I think it's good news rather than bad
Surly it’s not justified to drop that much on such midiyoka news.
Worth a punt from this level I’d say.
Today ....directors out and financial position RNS
What’s holding this up?
I am looking forward to the company's next update.
I'm a bit surprised that this company is not getting a bit more attention from funds that invest in tech start ups. Guess they prefer to invest in illiquid companies that have high, founder-led valuations!
At this price it looks very favourable in comparison to private tech companies. Plus already listed.
GPL is a focussed company with own patents/IP and sales pipeline. Got to be worth £3-5m even at these low revenues - that's around 2p per share.
As with too many on AIM the Mcap and SP is ridiculously low. Worth a punt so added 150k but shown as a sell.
The recent share issue has ensured that the company has a clean (no debt or overdue amounts owed to the board).
Position now looks like a good base on which to build and if GPL can progress some of its R&D relationships during 2024 into significant long term supply contracts the share price will revert to a more respectable level.
A year ago the SP was 13p so a 95% decline. This shows how awful AIM has become and ceasing to function as it should. The potential is there for a re-rate if GPL can deliver. News cannot be too far away. Bought 300k shares for 0.63p but shown as a sell.
OK, well that was more complicated than I think it needed to be. Still not sure who the 'new' cornerstone investor is or whether there actually was one.
Who is the new cornerstone investor and will they become a seller at the first chance? I don't think they're locked in.
Can't see a TR-1, although they must own c16% now.
Presumably, the incoming cornerstone investor has had an update on the pipeline. Hopefully PIs will get the benefit of this update shortly too?
Yes GPL has a lot of potential and Mcap of £1m is ridiculously low. This reflects the state of the market and lack of investors with risk appetite. So many instances on AIM of fund raise with huge discounts - some every week. Interim results on 27 September stated that "The Company is currently actively seeking additional funding, both non-dilutive and equity".
I prefer to wait the outcome as funds will be needed to support rapid expansion and satisfy due diligence of major customers. This is hard on companies that expected to raise funds at sensible terms rather than on the pit the market has become.
I have developed something of a (probably unhealthy) interest in this company over the last few weeks, buying in again today. They have core competencies in some really interesting/sustainability markets, each one of which could be significant.
There are risks abound here, which is reflected in the price - but considering them now alongside other unlisted tech start ups I think they are realistically priced. There's a good chance there will be a fundraise coming (they've stated as much) - but it is also a possibility that their R&D contracts together with a fair wind and delaying some payments, will get them through to early Spring when they can sign up full supply contracts and achieve cash positive.
Buried in the notes to the Interims announcement issued yesterday is the statement: "The Directors have confirmed that they are willing to forego fees in order to support the cash balance of the Group and will continue to monitor the net working capital position on a monthly basis".
This is commendable if it is happening. Also, the reference to monitoring the position on a monthly basis hints that they believe they have time to trade out and develop some of the research deals into full orders. The salaries of the board make up quite a chunk of their cash burn.
Yes, you’re right, current market conditions are awful and there are more companies delisting than listing on AIM it seems. Both Pelatro and Fulcrum Utility are leaving AIM in the next 7 days. They both say they’ll save the listing fees and be better placed to raise capital as a delisted company. You do wonder whether Graft Polymer might come to the same conclusion. Another reason to wait in the wings and see how this unfolds.
Yesterday MGC Pharma - the related company (common director in Roby Zomer) - announced a restructuring which will see existing shareholders of MGC diluted by up to 87.5%. https://mgcpharma.co.uk/investors/lse
You would think that GPL need to raise around £3m before costs if they want to have cash at least to see them through the next 12-18 months. Which with a discount on current share price, would potentially see dilution approaching 70% unless circumstances change or they go for less. Let's see.
AIM is currently awful for fund raising with often huge discounts to already depressed share prices. It does not function like it once did or should. Investment risk is always there but not at this level. Investors are very wary and few companies will newly list on AIM in these conditions.
Once funding sorted and when we have an idea of financial expectations based on recent series of RNS news (they don’t give any indication of anticipated revenue streams or profit) then it can be properly assessed whether or not this is a viable investment. TBF the purpose of AIM is to provide a way for companies like this to raise capital. I like this company ( I think) but there are significant unknowns so it’s a wait and see for me.